156 filings
20-F
2023 FY
CVAC
CureVac N.V.
Annual report (foreign)
24 Apr 24
5:39pm
6-K
CVAC
CureVac N.V.
24 Apr 24
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
4:30pm
6-K
CVAC
CureVac N.V.
24 Apr 24
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
4:20pm
6-K
CVAC
CureVac N.V.
24 Apr 24
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
4:15pm
6-K
CVAC
CureVac N.V.
16 Apr 24
CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
4:15pm
6-K
kuyfu95
4 Apr 24
CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
4:15pm
6-K
kovc16hyjaszpb7
17 Jan 24
CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock
9:02am
6-K
tah1ab
5 Jan 24
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development
4:15pm
6-K
t5ds44paebwz6cn3
19 Dec 23
CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE
4:30pm
6-K
ypq83w tjqm3be
14 Nov 23
Current report (foreign)
4:15pm
6-K
nwkim1irzmo ai
14 Nov 23
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business Update
4:15pm
6-K
2pkdnap
1 Nov 23
CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK
4:45pm
UPLOAD
2iznvny9y4pmx2v
19 Oct 23
Letter from SEC
12:00am
20-F/A
4dr42 euwaab
12 Oct 23
Annual report (foreign) (amended)
4:15pm
CORRESP
oz1yga9r8zya94sd
10 Oct 23
Correspondence with SEC
12:00am
6-K
71mdx2lz1 sf51g
28 Sep 23
CureVac Reports Progress in Intellectual Property Infringement Case Against BioNTech in Germany
4:30pm
UPLOAD
nxug0m76lpt9mio6ba
26 Sep 23
Letter from SEC
12:00am
6-K
0fx1txxqjnyv6vpf1hx9
12 Sep 23
Current report (foreign)
4:30pm
6-K
2067gupztv3mos8
17 Aug 23
Current report (foreign)
4:30pm
6-K
cgdxjf1l981y6 9uix
17 Aug 23
CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update
4:30pm